In contrast to other cell cycle inhibitors, the tumor suppressor p16
Ink4a is not detectable or expressed at very low levels in embryonic and adult mouse tissues, and therefore it has often been considered as a specialized checkpoint protein that does not participate in the control of normal cell cycle progression. However, Ink4a
À/À mice possess increased thymus size and cellularity, thus suggesting the involvement of p16
Ink4a in the control of thymocyte proliferation. In this study, we found increased numbers of CD8 and CD4 T lymphocytes in thymus and spleen from Ink4a À/À mice. Unexpectedly, this was not related to an increase in T-cell division rates, which were similar in lymphoid organs of Ink4a À/À and wild-type mice. In contrast, T-cell apoptosis rates were significantly decreased in thymus and spleen from Ink4a À/À mice. Moreover, whereas p16
Ink4a -deficient and wild-type T cells were equally sensitive to Fas or TCR-mediated apoptosis, the former were clearly more resistant to apoptosis induced by oxidative stress or gamma irradiation. Our results indicate that p16
Ink4a function is associated with Tcell apoptosis, and subsequently contributes to the control of T-cell population size in lymphoid organs. ; T lymphocyte; apoptosis; cell stress Tumor suppressors are proteins whose function may prevent cell transformation, and are frequently inactivated in cancer cells. While some tumor suppressors are ubiquitously expressed and play a central role in the control of normal cell proliferation, others are not detectable in most normal cells and tissues and lack any well characterized physiological function. The latter are considered as 'specialized' tumor-suppressor proteins. A major protein belonging to this category is the cyclin-dependent kinase (CDK) inhibitor p16 Ink4a (p16 hereafter). p16 is encoded by the Ink4a/Arf locus, that also codes for another tumor suppressor: the negative p53 regulator p19 Arf (p14 Arf in humans). The genetic structure of the Ink4a/Arf locus is unusual, because the two protein products are encoded in part by common nucleotide sequences that are read in alternative reading frames. p16 is the founding member of the Ink4 family of CDK inhibitors, that are able to prevent entry into cell cycle by inhibiting the phosphorylation of the retinoblastoma protein (pRb, reviewed in (Roussel, 1999) . p16 and pRb itself are the main tumor-suppressor proteins of the p16/pRb tumor-suppressor pathway, that is inactivated in most if not all tumors (Lowe and Sherr, 2003) . While pRb is ubiquitously expressed and plays a central role in the control of normal cell proliferation, p16 differs from other CDK inhibitors, including the other members of the Ink4 family, in that it is not expressed at detectable levels either during mouse development or in most adult tissues (Zindy et al., 1997) . In contrast, p16 can be easily detected in cultured human and mouse mesenchymal and epithelial cells, where its expression is associated with an irreversible growth arrest status (Voorhoeve and Agami, 2003) . It has been repeatedly reported that p16 expression can be induced in vitro by different forms of cell stress (Chazal et al., 2002; de Magalhaes et al., 2002; Chen et al., 2004) . These and other observations suggest that p16 is a checkpoint protein that does not participate in the control of normal cell proliferation, and whose expression is triggered only in some particular circumstances such as cell stress, cell senescence or the activation of certain oncogenes (Roussel, 1999; Lowe and Sherr, 2003) . However, some experimental evidence supports the possibility that p16 may be involved in the control of normal T-cell proliferation both in humans and mice. First, the only phenotype described thus far for Ink4a À/À mice, apart from their increased predisposition to develop tumors, is their enhanced thymic size and cellularity (Sharpless et al., 2001) . Second, when human T lymphocytes are cultured in vitro by repeated cycles of mitogenic stimulation, p16 expression is induced after every cycle of stimulation and is directly responsible for the exit of a significant proportion of the cells from the proliferative population (Migliaccio et al., 2005) .
To explore the possible role of p16 in the control of T-cell proliferation, we have compared the size of T-cell populations in thymus and spleen from 8 weeks-old FVB/n Ink4a À/À and wild-type mice. Higher numbers of double-negative CD4 À CD8
þ (DP) and single-positive CD4 (CD4SP) and CD8 (CD8SP) T cells were observed in thymus from
Ink4a
À/À mice ( Figure 1a ). Higher amounts of CD4 and CD8 T cells were also found in the spleen (Figure 1b ). These differences, although quantitatively modest, were statistically significant in all cases. In contrast, T-cell numbers were not altered in thymus and spleen from Arf À/À mice (Figure 1a and b), indicating that of the two tumor suppressors coded by the Ink4a/Arf locus, only p16 is involved in the control of T-cell population size.
As p16 is a cell cycle inhibitor, we considered that p16 deficiency could cause increased T-cell proliferation, as observed in mice deficient for other cell cycle inhibitors such as p27
Zip (Fero et al., 1996) or p18 Ink4c (Franklin et al., 1998) . To test this possibility, we first studied the cell cycle distribution of T-cell populations by Hoescht DNA staining. DN, DP, CD4SP and CD8SP thymocytes from Ink4a À/À and wild-type mice presented similar cell cycle distributions (Figure 2a and b) . Similarly, no differences were observed in the cycling rates of peripheral T cells from spleen (data not shown). In addition, isolated splenic T cells from Ink4a À/À and wildtype mice were equally able to proliferate in response to anti-CD3 or IL-15 ( Figure 2c ) and to Concanavalin A (Con A, data not shown). In these experiments, we observed no differences either in the proportion of cells recruited for proliferation (measured by BrdU incorporation, Figure 2c ), or in the cell division rate (determined by flow cytometry analysis of CFSElabelled cells, data not shown). All these results suggest that p16 is not involved in the control of cell cycle progression of normal murine T cells.
The size of T-cell populations in the analysed organs is, to some extent, the result of the balance between Tcell division and apoptosis rates. Thus, increased T-cell numbers could result not only from increased rates of proliferation, but also from decreased rates of apoptosis.
We measured the levels of apoptosis in T-cell populations from wild-type and Ink4a À/À mice by simultaneous annexin-V and 7-aminoactinomycin D (7-AAD) staining. Our results show that the percentages of apoptotic cells were significantly lower in CD4SP and CD8SP thymocyte populations from Ink4a À/À mice compared to controls (Figure 2d and e). DN and DP thymic populations from Ink4a À/À mice also presented slightly lower levels of apoptosis, but the observed differences were not statistically significant (Figure 2e ). Peripheral CD4 and CD8 T cells from spleen of Ink4a À/À mice also showed decreased levels of apoptosis ( Figure 2e ). These results indicate an association between p16 function and apoptosis rates of CD4 and CD8 T cells in vivo, and suggest that p16 is required for triggering cell death in a proportion of thymocytes during the last stages of T-cell development, and also during peripheral T-cell homeostasis.
As in other cells, T-cell apoptosis can be induced via extrinsic or intrinsic pathways. Extrinsic pathways include signals delivered after activation of specific receptors. In T cells, one of the most important and best characterized of these receptors is Fas (CD95), which plays important roles during T-cell development and mediates the process known as activation-induced cell death. In addition, signals derived as a result of TCR engagement can induce not only proliferation, but also cell death (Marrack and Kappler, 2004) . We used a FasL-Fc fusion protein (Holler et al., 2003) and the mitogen ConA to induce respectively Fas-mediated and TCR-mediated apoptosis in vitro on T cells obtained from Ink4a
À/À and wild-type mice. After 20 h, no differences in apoptosis rates were observed in CD8 T cells from spleen ( Figure 3a mice were kindly provided by Dr RA De Pinho and Dr A Trumpp, respectively; age-matched FVB/n and C57BL/6 wild-type mice were used as controls. Thymocytes and splenocytes from 8-week-old mice were stained with fluorochrome-conjugated mAbs against TCRab, CD4 and CD8 (LICR, Switzerland and eBiosciences) and analysed by flow cytometry with a FACSCanto Flow Cytometer (BD Biosciences). The observed frequencies of CD4SP and CD8SP thymocytes were multiplied by the total cell counts to calculate the total number of CD4 and CD8 T cells for every animal in the thymus (a) and spleen (b). Columns and error bars represent mean values7s.d.; n ¼ 10 matched pairs, mice from three independent litters were used for every genotype. Double asterisks indicate that differences with controls were statistically significant (Po0.01) in a Student's t-test. À/À and wild-type mice (n ¼ 5 age-matched pairs) were cultured at 3 Â 10 6 cells/ml in complete medium (DMEM, 10%FCS, 1 mM Hepes and 50 mM 2-b-mercaptoethanol) and stimulated with anti-CD3 (10 mg/ ml) (145.2C11, LICR) or recombinant human IL-15 (100 ng/ml) (R&D Systems). BrdU (10 mg/ml) was added in each culture and, after the indicated incubation times, BrdU uptake was measured following the manufacter's instructions using the BrdU staining kit (BD Biosciences) together with TCRab, CD4 and CD8 surface staining. Bar graphs show the mean percentages7s.d. of BrdU þ cells gated on CD8 T cells. (d and e) Freshly isolated single cell suspensions of thymocytes or splenocytes were incubated 1 or 18 h at 371C to allow Annexin-V expression. Cells were then surface stained for TCRab, CD4 and CD8, washed and resuspended in Â 1 Annexin-V Binding buffer (BD Biosciences) at 1 Â 10 6 cells/ml. A total of 0.3 Â 10 6 cells were stained with Cy5-conjugated Annexin-V (BD Biosciences) following manufacturer's instructions. An equal volume of Â 1 Annexin-V Binding buffer was added and samples were analysed À/À and wild-type mice (n ¼ 10 age-matched pairs, both Ink4a À/À and wt mice were from three different litters). **Po0.01.
Role of p16
Ink4a in the stress response of T lymphocytes T Bianchi et al
Ink4a in the stress response of T lymphocytes T Bianchi et al (Holler et al., 2003) was kindly provided by Dr J Tschopp. Thymocytes from the same mice were cultured in the same conditions and treated with H 2 O 2 (c), gamma-irradiated (d) or treated with the indicated concentrations of dexamethasone (Sigma, f). Untreated control samples were included in every case. After 20 h, cultured splenocytes and thymocytes were collected and stained with mAbs against TCRab, CD4 and CD8, and then with Cy-5-conjugated Annexin-V as described in Figure 2 TCR-mediated apoptosis was induced by anti-CD3 (data not shown), and parallel data were obtained with CD4 T cells (data not shown). Our results indicate that p16 is not involved in these well-studied examples of receptor-mediated T-cell apoptosis. Apoptosis can also occur through intrinsic pathways driven by signals generated within the T-cell itself. Intrinsic apoptotic pathways are usually focused on the mitochondrion and their activation can be triggered by several stimuli, including some drugs, hormones, and different forms of cell stress. We have analysed the apoptotic response to the glucocorticoid analog dexamethasone, to oxidative stress induced by hydrogen peroxide (H 2 O 2 ) and to DNA damage induced by gamma irradiation in T cells from spleen and thymus. Sensitivity to dexamethasone was similar in DP, CD8SP and CD4SP thymocytes from wild-type and Ink4a À/À mice (Figure 3f ), indicating that p16 is not involved in the response to glucocorticoids, which play an important role in the control of apoptosis during T-cell development (Ashwell et al., 2000) . Similar results were obtained with splenic T cells (data not shown). In contrast, we found that sensitivity to both oxidative stress and gamma irradiation were significantly decreased in p16-deficient CD8 T cells from spleen and thymus (Figure 3c-e) . Similar differences were observed with CD4 T lymphocytes, even if these cells were slightly more resistant to apoptosis than CD8 T cells (data not shown).
Ink4a
In summary, our results indicate that the increased size of splenic and thymic T-lymphocyte populations in p16-deficient mice is associated with lower levels of spontaneous apoptosis in vivo and increased resistance to stress-induced apoptosis in vitro. We, therefore, favor the hypothesis that these differences are caused by a cellautonomous lack of p16 protein in T cells. However, we cannot formally exclude the possibility that the absence of p16 in other cells involved with T-cell homeostasis and maturation, such as thymic epithelial cells or dendritic cells, may indirectly influence the physiology of T cells. Additional experiments with chimeric Ink4a/ wt mice are required to test this possibility.
Our results also indicate that p16 deficiency does not alter the level of T-cell proliferation naturally observed in vivo, and in response to mitogens or IL-15 in vitro. However, it is still formally possible that p16 controls proliferation in a very small early T-cell precursor population, and this function might have a substantial effect on total T-cell numbers. To explore this possibility, we have extended our cell cycle analysis to immature subsets of DN thymocytes characterized by their expression of CD25 and CD44. For all analysed subsets, no significant differences in cycling were found between cells from Ink4a À/À and wild-type mice (data not shown). Nevertheless, this hypothesis cannot be completely ruled out at present and should be the subject of further investigation.
Induction of p16 expression seems to be part of a mechanism that irreversibly deprives the cell of its capacity to divide. Several studies have shown that, in cultured mesenchymal or epithelial cells, p16 expression leads to an irreversible growth arrest state that resembles in several aspects replicative senescence (Serrano and Blasco, 2001) . In contrast, our results indicate that p16 expression in T cells leads to apoptosis, suggesting that the consequences of p16 expression may vary among different cell types. This could make sense from a physiological point of view: p16-positive mesenchymal or epithelial cells can be perfectly functional even if they have lost replicative capacity, while p16-expressing lymphoid cells are most probably nonfunctional, because their functionality depends to a large extent on their capacity to divide in response to antigenic stimulation. Similar differences between cell types have been observed in response to the cell cycle inhibitor p21 Cip1/Waf1 , that typically induces growth arrest in fibroblasts and other adherent cells, but promotes apoptosis in T lymphocytes when induced in response to FasL (Hingorani et al., 2000) . Further supporting a link between p16 expression and cell death in lymphoid cells, p16 can interfere with Abl-mediated transformation of primary B cells by enhancing apoptosis (Sachs et al., 2004) and transgenic p16 expression prevents expansion and survival of DN immature thymocytes (Lagresle et al., 2002) . In contrast, Ink4a À/À mouse embryo fibroblasts have increased sensitivity to UV-induced apoptosis (Al-Mohanna et al., 2004) , reinforcing the idea that p16 expression in these cells is related to irreversible growth arrest rather than cell death.
It has been reported that p16 expression can be induced by oxidative stress in cultured adherent human cells (de Magalhaes et al., 2002; Chen et al., 2004) . DNA damage triggered by different agents such as UV light and chemicals can also induce p16 expression (Chazal et al., 2002) , whereas p16 inactivation has been reported in gamma irradiation-induced thymic lymphomas (Malumbres et al., 1997) . Using p16-deficient cells, our study presents direct evidence of the involvement of p16 in the apoptotic response to both forms of cell stress in T cells. The precise intracellular pathways activated during these responses remain to be elucidated. Ink4a À/À and wild-type mice showed similar levels of Bcl-2 protein as measured by intracellular staining and flow cytometry (data not shown), indicating that resistance to oxidative stress and DNA damage is not mediated by increased Bcl-2 expression. This is relevant since Bcl-2 plays a major role in the control of T-cell apoptosis, and increased Bcl-2 expression can mediate resistance to apoptosis induced by diverse stimuli, including oxidative stress (Amstad et al., 2001) .
Reactive oxygen species (ROS), including H 2 O 2 , have been repeatedly suggested to play an important role in the modulation of T-cell activation (Cemerski et al., 2003; Remans et al., 2004; Rodriguez-Mora et al., 2005) , and in the control of T-cell survival (Kim and Nel, 2005) . Intrathymic and intrasplenic oxidative stress is induced in acutely exercised mice, and leads to highly increased levels of apoptosis in thymus and spleen (Azenabor and Hoffman-Goetz, 1999) . A similar phenomenon has been described for intestinal lymphocytes (Quadrilatero and Hoffman-Goetz, 2004) . In this sense, our results point out the possibility that p16 mediates a ROS-dependent mechanism controlling Tcell survival. Chronic oxidative stress can also lead to Tcell hyporesponsiveness to proliferative stimuli (Cemerski et al., 2003; Remans et al., 2004; Rodriguez-Mora et al., 2005) and is thought to underlie altered, pathologic T-cell behavior in a number of human diseases including rheumatoid arthritis (Cope, 2002) and HIV infection (Cayota et al., 1996) . Further investigation would be required to determine if p16 is involved in these phenomena.
Taken together, our results suggest that p16 plays a physiological role in the control of T-cell survival during T-cell development and homeostasis. This may be due to the fact that ROS themselves are physiologic mediators of these processes. p16 function as a T-cell survival regulator may be important for the correct development and homeostasis of an efficient immune system, thereby contributing to the conservation of this protein through evolution. Future experiments addressing the immune response in p16-deficient mice may shed further light on this hypothesis.
